Blueprint Medicines Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BPMC research report →
About the company
Blueprint Medicines Corporation is a biopharmaceutical company dedicated to pioneering precision therapies. Its core mission involves developing innovative treatments for various cancers and specific blood disorders, specifically those identified by genomic markers. These efforts extend to patients both within the United States and across international markets.
- CEO
- Kathryn Haviland
- IPO
- 2015
- Employees
- 682
- HQ
- Cambridge, MA, US
Price Chart
- Market Cap
- $8.36B
- P/E
- -121.29
- P/S
- 16.43
- P/B
- 27.25
- EV/EBITDA
- 453.77
- Div Yield
- 0.00%
- Gross Margin
- 96.04%
- Op Margin
- -41.67%
- Net Margin
- -13.19%
- ROE
- -31.26%
- ROIC
- -21.72%
- Revenue
- $508.82M · 104.04%
- Net Income
- $-67,089,000 · 86.77%
- EPS
- $-1.07 · 87.22%
- Op Income
- $-212,044,000
- FCF YoY
- 56.46%
- 52W High
- $129.55
- 52W Low
- $73.04
- 50D MA
- $116.52
- 200D MA
- $98.82
- Beta
- 0.83
- Avg Volume
- 3.29M
Get TickerSpark's AI analysis on BPMC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 17, 25 | Landsittel Michael | other | 21,353 |
| Jul 17, 25 | Landsittel Michael | sell | 51,102 |
| Jul 17, 25 | Landsittel Michael | sell | 25,000 |
| Jul 17, 25 | Landsittel Michael | sell | 25,000 |
| Jul 17, 25 | Landsittel Michael | sell | 10,000 |
| Jul 17, 25 | Landsittel Michael | other | 43,175 |
| Jul 17, 25 | Landsittel Michael | sell | 19,500 |
| Jul 17, 25 | Landsittel Michael | sell | 25,000 |
| Jul 17, 25 | Landsittel Michael | sell | 25,000 |
| Jul 17, 25 | Landsittel Michael | sell | 22,000 |
Our BPMC coverage
Recent articles, reports, and earnings notes.
No research on BPMC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BPMC report →Similar companies
Peers in the same neighborhood.